First Tracks Biotherapeutics: Leerink Partners raises target price to $90 from $70
TRAX•Leerink Partners raised its target price for First Tracks Biotherapeutics to $90 from $70.
Related News
Truist's Q3 adjusted EPS beats estimates
TFC•
Street view: US Bancorp shrugs off weak spots, keeps the cheers coming
USB•
Fermi amends MUFG financing agreement to remove 400 MW lease covenant
FRMI•
Firy redeems all $49.67 million in outstanding debt
FIRY•
BTIG raises Twilio target price to $315 from $285
TWLO•